HoYAG vs TFL in miniPCNL With ClearPetra
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Kansas Medical Center
About this trial
Mini percutaneous nephrolithotripsy is the treatment of choice for kidney stones over 2cm. This procedure commonly uses laser energy for breaking the stones, and among possible laser platforms, Hoyag and thulium fiber laser are FDA approved. Recently, this procedure has also included the use of vacuum assisted renal access sheaths, which allows suction to be employed together with the breaking of stones. This study intends to compare outcomes when using either laser platforms with suction sheaths in participants undergoing mini percutaneous nephrolithotripsy for the treatment of kidney stones.
Eligibility criteria
Qualifiers
Males or females over 18 years of age
Patients with kidney stones, with stone burden larger than 15 mm.
Patients undergoing new percutaneous access with primary, supine, unilateral mini-PCNL.
Disqualifiers
Simultaneous use of more than 1 laser platform or other form of fragmentation (e.g., ultrasonic).
Patients undergoing simultaneous treatment of contralateral kidney stones during the same procedure.
Patients undergoing simultaneous treatment of ureteral stones during the same procedure.
Pregnant patients.
Trial design
Treatments tested in this trial
- HoYAG laser
- TFL laser platform
Treatment groups
150 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Kansas Medical Center
Lead sponsor
Boston Scientific Corporation
Collaborator
Source ClinicalTrials.gov